The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease
Open Access
- 26 October 2004
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 91 (10) , 1755-1757
- https://doi.org/10.1038/sj.bjc.6602211
Abstract
The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were rs=0.632, Prs=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease.Keywords
This publication has 20 references indexed in Scilit:
- The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancerBritish Journal of Cancer, 2004
- Interleukin‐6: minor player or starring role in the development of hormone‐refractory prostate cancer?BJU International, 2003
- Systemic inflammatory response predicts survival following curative resection of colorectal cancerBritish Journal of Surgery, 2003
- Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancerAnnals of Surgical Oncology, 2000
- High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomyUrology, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- In vivoEffect of Recombinant Human Leukemia Inhibitory Factor in PrimatesJapanese Journal of Cancer Research, 1997
- Pre-treatment serum levels of tumour markers in metastatic breast cancer: a prospective assessment of their role in predicting response to therapy and survivalEuropean Journal of Surgical Oncology, 1995
- Systemic administration of ciliary neurotrophic factor induces cachexia in rodents.Journal of Clinical Investigation, 1994
- Tumour Markers as Prognostic Aids in Prostatic CarcinomaBritish Journal of Urology, 1990